These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32673607)

  • 21. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.
    King DS; Trudgill NJ; Adderley NJ
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1442-1443. PubMed ID: 32406090
    [No Abstract]   [Full Text] [Related]  

  • 22. Italian IBD Patients Coping With Covid-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-care.
    Castellini G; Savarese M; Leone S; Previtali E; Armuzzi A; Graffigna G
    Inflamm Bowel Dis; 2020 Sep; 26(10):e130-e131. PubMed ID: 32720983
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and Psychological Issues in Children with Inflammatory Bowel Disease During COVID-19 Pandemic.
    Martinelli M; Strisciuglio C; Fedele F; Miele E; Staiano A
    Inflamm Bowel Dis; 2020 Aug; 26(9):e95-e96. PubMed ID: 32440675
    [No Abstract]   [Full Text] [Related]  

  • 24. Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
    Prentice RE; Tjandra D; Garg M; Lubel JS; Fourlanos S; Johnson D; Al-Ani A; Christensen B
    Aliment Pharmacol Ther; 2020 Oct; 52(8):1422-1423. PubMed ID: 33105980
    [No Abstract]   [Full Text] [Related]  

  • 25. Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.
    Benson-Pope SJ; Gearry RB
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1441-1442. PubMed ID: 32406119
    [No Abstract]   [Full Text] [Related]  

  • 26. Response to "Italian IBD Patients Coping With COVID-19 Emergency: The Mitigating Role of Psychological Readiness to Engage in Self-Care".
    Occhipinti V; Sociale OR; Pastorelli L
    Inflamm Bowel Dis; 2020 Sep; 26(10):e123. PubMed ID: 32720980
    [No Abstract]   [Full Text] [Related]  

  • 27. Resumption of daily services in a gastroenterology department in Guangzhou, China, in the wake of COVID-19.
    Han J; Zhu L; Wang Y; Zeng Z; Zhang S
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):645-646. PubMed ID: 32380008
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre.
    Zingone F; Buda A; Savarino E
    Dig Liver Dis; 2020 Nov; 52(11):1248-1249. PubMed ID: 32811778
    [No Abstract]   [Full Text] [Related]  

  • 29. Noninvasive monitoring of inflammatory bowel disease in the post COVID-19 era.
    Nardone OM; Rispo A; Castiglione F
    Dig Liver Dis; 2020 Nov; 52(11):1236-1237. PubMed ID: 32741684
    [No Abstract]   [Full Text] [Related]  

  • 30. Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
    Allocca M; Fiorino G; Furfaro F; Gilardi D; Radice S; D'Amico F; Zilli A; Danese S
    Clin Gastroenterol Hepatol; 2020 Jul; 18(8):1882-1883. PubMed ID: 32304737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for active COVID-19 infection prior to biologic therapy in IBD patients: Let's not increase our uncertainty without reducing our concerns.
    Festa S; Aratari A; De Biasio F; Fascì-Spurio F; Papi C
    Dig Liver Dis; 2020 Nov; 52(11):1246-1247. PubMed ID: 32527654
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of inflammatory bowel diseases in the wake of COVID-19 pandemic.
    Pasha SB; Fatima H; Ghouri YA
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1449-1450. PubMed ID: 32246874
    [No Abstract]   [Full Text] [Related]  

  • 33. Systematic review on failure to adhere to IBD therapies during the COVID-19 pandemic: Correct information is crucial.
    Jena A; Singh AK; Kumar-M P; Sharma V; Sebastian S
    Dig Liver Dis; 2020 Nov; 52(11):1254-1256. PubMed ID: 33011089
    [No Abstract]   [Full Text] [Related]  

  • 34. [Chronic inflammatory bowel disease and COVID-19].
    Moum B
    Tidsskr Nor Laegeforen; 2020 May; 140(7):. PubMed ID: 32378846
    [No Abstract]   [Full Text] [Related]  

  • 35. Excessive anxiety in IBD patients is unnecessary for COVID-19.
    Wang HG; Xie R; Ma TH; Yang XZ
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):e121-e122. PubMed ID: 32409282
    [No Abstract]   [Full Text] [Related]  

  • 36. Biologic Therapies May Reduce the Risk of COVID-19 in Patients With Inflammatory Bowel Disease.
    Bezzio C; Pellegrini L; Manes G; Arena I; Picascia D; Della Corte C; Devani M; Schettino M; Saibeni S
    Inflamm Bowel Dis; 2020 Sep; 26(10):e107-e109. PubMed ID: 32869831
    [No Abstract]   [Full Text] [Related]  

  • 37. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in paediatric inflammatory bowel diseases in the COVID-19 time.
    Dipasquale V; Cucchiara S; Martinelli M; Miele E; Aloi M; Romano C
    Dig Liver Dis; 2020 May; 52(5):593-594. PubMed ID: 32276846
    [No Abstract]   [Full Text] [Related]  

  • 39. Separated pathways in the endoscopy unit for COVID-19 patients.
    Cortegoso Valdivia P; Le Grazie M; Gaiani F; Decembrino F; De' Angelis GL
    Gastrointest Endosc; 2020 Jul; 92(1):239. PubMed ID: 32229132
    [No Abstract]   [Full Text] [Related]  

  • 40. Viral screening before initiation of biologics in patients with inflammatory bowel disease during the COVID-19 outbreak.
    Zingone F; Savarino EV
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):525. PubMed ID: 32220656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.